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Case Report
Isolated Adrenocorticotropic Hormone (ACTH) Deficiency and 
Thyroid-Stimulating Hormone (TSH)-Thyroid Hormone Derangement: 
Report of Three Cases
Shigemitsu Yasuda, Seiki Wada, Miho Suzuki, Akinobu Minagawa,
 Shinji Kitahama, Makoto Iitaka, Shigehiro Katayama
Department of Endocrinology and Diabetes, Institute of Internal Medicine, Saitama Medical School, Moroyama, 
Iruma-gun, Saitama 350 -0495, Japan
Abstract: We present three cases of isolated adrenocorticotropin (ACTH) deficiency accompanied by derangement 
of the thyroid-stimulating hormone (TSH)-thyroidal axis. Thyroid hormone and TSH levels were evaluated before 
and after cortisol replacement. Although markedly elevated levels of TSH were noted in one case, this patient also 
showed typical features of Hashimoto’s thyroiditis. In the other two cases, basal TSH levels were increased, and 
replacement of cortisol reversed the values. We have previously reported that interference of thyroid hormone 
synthesis and/or secretion by glucocorticoid deficiency is a major cause of TSH-thyroidal axis derangement. 
However, it has been shown that a considerable number of reported cases exhibit severe hypothyroidism due to 
Hashimoto’s thyroiditis, as was shown in case 2. It has been recognized that, whether the origin is the pituitary or 
the adrenal gland, polyglandular failure is a complex of autoimmune endocrinopathy. Alternatively, it is assumed 
that depletion of the physiological concentration of cortisol may worsen hypothyroidism due to Hashimoto’s 
thyroiditis, possibly through modification of  T cell function. Since transient abnormalities of the TSH-thyroidal 
axis and growth hormone could occur in glucocorticoid-deficient patients along with derangement of other 
pituitary hormones, hormonal evaluation should be carried out after a sufficiently long interval following cortisol 
replacement.
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Introduction
　Isolated adrenocor ticotropic hormone (ACTH) 
deficiency is regarded as a rare disorder characterized 
by hypocortisolism. It has been reported that this 
disorder is often accompanied by derangement of the 
thyroid-stimulating hormone (TSH)-thyroidal axis1-3). As 
a considerable number of patients with isolated ACTH 
deficiency have been proven to possess circulating 
auto-antibodies against pituitary cells4), this disease is 
presumed to be caused by an autoimmune mechanism. 
We have previously repor ted that the abnormality 
in the pituitary-thyroid axis is transient, and can be 
reversed by glucocorticoid replacement5). A literature 
survey revealed that interference of thyroid hormone 
synthesis and/or secretion by glucocorticoid deficiency 
is the major cause of the thyroid dysfunction, rather 
than autoimmune thyroid disease5).  However, we 
have also noticed that a considerable number of cases 
are accompanied by severe hypothyroidism due to 
Hashimoto’s thyroiditis or primary hypothyroidism6 -8). 
Here we describe three cases of isolated ACTH 
deficiency experienced recently at our hospital and 
discuss the possible relationship between ACTH 
deficiency and the TSH-thyroidal axis. 
Case reports
Case 1
A 64-year-old man was admitted to Saitama Medical 
School Hospital because of general fatigue and weight 
loss. He had lost 14 kg in weight over the previous 
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11 months. Physical examination showed emaciation 
with a body weight of 40 kg and height of 160 cm. 
Body temperature was 36.2 ℃ , pulse rate was 58/min, 
and blood pressure was 136/74 mmHg. There was 
no hyperpigmentation on his skin or mucosa. The 
thyroid gland was normal in size and consistency. Blood 
chemistr y revealed hypoglycemia (fasting plasma 
glucose (FPG): 59 mg/dl), a slightly high creatinine 
kinase level (234 IU/l), and hyponatremia (121 mEq/l). 
Hematological tests revealed a white blood cell count of 
6870/µl with 18.1 % eosinophils. Basal endocrinological 
data are shown in Table 1, and the results of various 
hormone-stimulating tests are summarized in Table 2. 
Auto-antibodies against the pituitary and thyroid glands 
were all negative. Magnetic resonance imaging (MRI) 
of the head showed no specific lesion around the 
pituitary gland. Basal endocrinological data as well 
as various hormone-stimulating tests showed central 
hypocortisolism with mildly elevated TSH values. These 
data indicated that the most compatible diagnosis was 
isolated ACTH deficiency. The patient’s symptoms 
gradually improved after hydrocortisone replacement. 
Without thyroid hormone replacement, increased levels 
of TSH and responses to TRH returned to the reference 
range, as shown in Table 3.
Case 2
A 58-year-old woman was referred to Saitama Medical 
School Hospital for evaluation and treatment of 
hypoglycemia.  She had been suffering from generalized 
edema and loss of appetite. Due to loss of consciousness, 
she was treated at an emergency unit and found to have 
bradycardia (48/min) and pericardial effusion. Since 
laboratory tests showed positive anti-thyroid antibodies 
and decreased thyroid hormone levels, she had been 
treated as having hypothyroidism due to Hashimoto’s 
thyroiditis. Replacement of L-thyroxine had improved 
her general condition, but hypoglycemia was observed 
(32 mg/dl). To examine further the pathogenesis of 
the fasting hypoglycemia, she was referred to our 
hospital. Her condition was relatively good with a body 
weight of 47 kg and height of 148 cm. Blood pressure 
was 128/96 mmHg and heart rate was 64/min. No 
hyperpigmentation was obser ved on her skin and 
mucosa. The thyroid gland was mildly enlarged. Blood 
chemistry showed elevation of the total cholesterol 
(243 mg/dl) and creatinine kinase (387 IU/ml) levels. 
The serum sodium concentration was 136 mEq/l and 
FPG was 38 mg/dl. Basal endocrinological data and 
results of various hormonal tests under L-thyroxine 
replacement (50 µg/day) are summarized in Tables 1 
and 2, respectively.  Anti-pituitary auto-antibodies were 
negative and thyroid-related antibodies were positive: 
the titer of thyroperoxidase antibody was higher than 
30 U/ml and that of thyroglobulin antibody was more 
than 100 U/ml. Along with the decreased levels of ACTH 
GH: growth hormone; LH: Luteinizing hormone; FSH: Follicle-stimulating 
hormone; ACTH: adrenocorticotropin; TSH: thyroid-stimulating hormone; KS: 
ketosteroids; OHCS: hydroxycorticosteroids
Table 1. Basal endocrinological data
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and cortisol, it was found that growth hormone(GH) did 
not respond well against GH-releasing hormone (GRH) 
and insulin-induced hypoglycemia. MRI did not reveal 
any lesions around the pituitary.  Findings of thyroid 
sonography, i.e. decreased and non-homogeneous 
echogenicity, were compatible with the diagnosis of 
Hashimoto’s thyroiditis. These data indicated that 
the case was most compatible with a diagnosis of 
partial hypopituitarism with hypothyroidism due to 
Hashimoto’s thyroiditis. However, as Hashimoto et al.9) 
had noted that the low or absent response of GH in 
cases of isolated ACTH deficiency would recover after 
cortisol replacement, the GH response was re-evaluated 
after replacement of hydrocortisone (20 µg/day) and 
L-thyroxine (100 µg/day). Three months later, basal 
pituitary hormonal levels as well as the GH response 
were studied, and it was found that the diminished 
response of GH against GRH had improved (Table 3).
Case 3
A 64-year-old man was referred to Saitama Medical 
School Hospital for evaluation and treatment of 
hematological abnormalities. He had been well until 18 
months before, when he noticed general fatigue and 
persistent cramp in the lower extremities. He had lost 
6 kg in weight over the previous year. His weight was 
48 kg and height was 159 cm. Body temperature was 
36.6 ℃ , pulse rate was 78/min, and blood pressure was 
150/96 mmHg. No hyperpigmentation was observed 
on his skin or mucosa. His thyroid gland was normal 
in size and consistency. Hematological examination 
showed hypochrolemic and hypovolemic anemia (Hb 
10.9 g/dl, MCV 89.4 fl, MCH 28.1 pg, MCHC 31.4 %) 
and thrombocytopenia (75,000 /µl). Blood chemistry 
revealed hyponatremia (126 mEq/l ) and mild elevation 
of the creatinine kinase level (243 IU/l). His fasting 
plasma glucose level was 52 mg/dl. To examine the 
hyponatremia and low plasma glucose, we evaluated 
his hormonal status. Basal endocrinological data and 
results of hormone-stimulating tests are shown in 
Tables 1 and 2. In addition to the decreased levels of 
ACTH and cortisol, it was found that GH responded to 
neither GRH nor L-arginine. Auto-antibodies against 
pituitary and thyroid were negative. MRI of the head 
showed no specific lesion around the pituitary gland. 
Anemia and thrombocytopenia improved 3 months 
after cortisol replacement. As in case 2, we re-evaluated 
the patient’s hormonal status and found that the low 
response of GH against GRH was improved. 
Discussion
Several hormonal abnormalities have been reported 
in cases of isolated ACTH deficiency5, 7, 9).  We and 
others have demonstrated increased basal TSH or 
Table 2. Hormone-stimulating tests (before replacement)
Table 3. Hormone-stimulating tests (after replacement)
Anterior pituitary hormones and cortisol responses were 
assessed by administration of CRH (100 mg), TRH (500 
mg), GRH (100 mg), l-arginine (30 g), and insulin (0.05 
U/kg).  CRH: corticotropin-releasing hormone; GRH: growth 
hormone-releasing hormone; TRH: thyrotropin-releasing 
hormone.  Response of these pituitar y hormones was 
described in ref. 16.
TSH and GH responses were re-assessed by administration of 
TRH (500 mg) and GRH (100 mg) after hormone replacement
118 Shigemitsu Yasuda, et al ACTH deficiency and thyroid
TSH hyper-responsiveness to TRH in about half 
of all repor ted cases; increased basal TSH levels 
were observed even in patients with normal thyroid 
hormone values. To date, several interactions between 
glucocorticoid and the pituitary-thyroid axis have been 
reported9, 10). It is suggested that the physiological 
concentration of glucocor ticoid has a suppressive 
ef fect on TSH secretion. Glucocorticoid deficiency 
may therefore be one of the causes of the increased 
basal TSH level in isolated ACTH deficiency. Similarly, 
the cases presented also showed increased values of 
basal TSH.  Hyper-responsiveness of TSH to TRH was 
diminished after hydrocortisone replacement, although 
the values of TSH were only observed until 60 min 
after TRH administration. It is likely that glucocorticoid 
affects thyroid hormone synthesis and/or secretion 
more easily in patients with intrinsic thyroid disease. 
TSH secretion can be impaired not only quantitatively, 
but also qualitatively11): TSH secreted in response 
to TRH is biologically inactive in some cases of 
hypothalamic hypothyroidism. It is therefore possible 
that elevated levels of TSH in isolated ACTH deficiency 
would have no stimulatory effect on the thyroid gland.
　In a review of 103 reported cases with isolated ACTH 
deficiency, we found that 12.6 % of the patients were 
positive for anti-thyroid antibodies5). Autoimmune 
thyroiditis is common in both female and male Japanese 
individuals, and the prevalence of autoimmune thyroid 
disease among patients with isolated ACTH deficiency 
was almost the same in the general Japanese population. 
However, we also noticed that a considerable number 
of the patients had severe hypothyroidism due to 
Hashimoto’s thyroiditis, as seen in the second of the 
present cases6 -8). There must be a unique relationship 
between hypocortisolism and Hashimoto’s thyroiditis; 
primar y adrenal insuf ficiency accompanied by 
Hashimoto’s thyroiditis was a well-known complex of 
polyglandular autoimmune syndrome12). It is mostly 
recognized that, whether the origin is the pituitary or 
the adrenal gland, polyglandular failure is a complex 
of autoimmune endocrinopathy. Furthermore, there 
may be an additional explanation that a depleted 
physiological concentration of cortisol may worsen 
hypothyroidism due to Hashimoto’s thyroiditis possibly 
through modification of T-cell function. It has been 
reported that codon 17 polymorphism of the cytotoxic 
T lymphocyte antigen 4 (CTLA4) gene is related to 
Hashimoto’s thyroiditis and Addison’s disease13). An 
alanine residue at CTLA4 codon 17 confers genetic 
susceptibility to Hashimoto’s thyroiditis, and this was 
shown to apply to the subgroup with the susceptibility 
marker, human leukocyte antigen DQA1*0501+, in 
patients with adrenal hypocortisolism13).  It would 
therefore be intriguing to investigate T-cell function 
and CTLA4 gene in cases of isolated ACTH deficiency 
as well. 
It has been shown that serum GH levels change 
little or not at all in response to GRH, insulin-induced 
hypoglycemia, glucagon and l-arginine in patients 
with isolated ACTH deficiency; GH secretion is more 
responsive than before hydrocortisone replacement 
in 78.9 % of cases9). These results suggest that the 
impaired GH response in ACTH-deficient patients is 
due mostly to hypocortisolism. It is well known that 
an excess dosage of hydrocortisone suppresses GH 
secretion in patients with Cushing syndrome and 
patients treated with high-dose glucocor ticoids14). 
It has also been shown that cortisol replacement in 
physiological daily doses increases GH output in 
patients with Addison’s disease by augmenting GH 
pulse amplitude and interpulse levels15). This is likely 
due to attenuation of hypothalamic somatostatin 
secretion by physiological levels of cortisol, implying 
that hypocor tisolism leads to diminution of GH 
output with a low GH pulse amplitude. Therefore, it is 
suggested that a physiological dosage of glucocorticoid 
is indispensable for normal GH secretion.
The patients presented here were diagnosed as 
having isolated ACTH deficiency, according to the 
typical endocrinological findings as well as hormonal 
re-evaluation after a suf ficient time inter val on 
replacement therapy.  In case 2, the patient had been 
supplemented with L-thyroxine before hypocortisolism 
replacement.  It is generally recognized that thyroxine 
therapy should be carried out after evaluation of 
ACTH-cortisol axis, which might contribute to earlier 
diagnosis of this rare complex of isolated ACTH 
deficiency and severe hypothyroidism.  Forster et al. 
reported that polyglandular autoimmune syndrome 
occurred relatively often among patients visiting a 
core medical center, with a 3:1 female to male ratio12). 
Although the etiology of severe hypothyroidism due 
to Hashimoto’s thyroiditis seen in isolated ACTH 
syndrome is uncertain, depletion of the physiological 
concentration of cor tisol may worsen the thyroid 
destruction through an autoimmune mechanism. Since 
transient abnormalities of pituitary hormones could 
occur in glucocorticoid-deficient patients, hormonal 
evaluation should be carried out after a sufficient period 
of cortisol replacement.  
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症例報告
副腎皮質刺激ホルモン（ACTH）単独欠損症における甲状腺刺激ホルモン-甲状腺ホルモン値異常：3例報告
安田重光，和田誠基，鈴木美穂，皆川晃伸，北濱眞司，飯高誠，片山茂裕
　ACTH単独欠損症では，しばしば甲状腺ホルモン異常が合併するとの報告がある．本論文では副腎皮質刺激ホ
ルモン（ACTH）単独欠損症における甲状腺刺激ホルモン（TSH）-甲状腺ホルモン値異常に関して，コルチゾール
補充前および補充後に評価し得た 3例に関して報告した．1例ではTSH値の顕著な上昇を認めるとともに甲状
腺自己抗体の存在および特徴的な超音波所見から橋本病の合併と診断し得たが，その他の2例ではコルチゾー
ル補充のみでTSH値上昇は低下し，橋本病の合併は否定された．我々は以前，本症のTSH高値がコルチゾール
欠乏による分泌異常であり，生物学的活性を示さない可能性に関して言及したが，その後も本症に自己免疫性
甲状腺疾患の橋本病による高度な甲状腺機能低下症を合併したとの報告は多い．本症での甲状腺機能異常は多
腺性内分泌障害の可能性も考えられるが，コルチゾール欠乏が免疫応答に異常を来している可能性も否定でき
ない．ACTH単独欠損症のみならずコルチゾール欠乏状態ではTSHや成長ホルモン値の高値を認める場合も多く，
初診時に的確な診断は困難であり，それらはコルチゾール補充後に再評価し診断を導く必要があると考えられた．
